Table 5 Comparison of epidemiological data for ANA-positive patients RR-positive, ANA-positive RR-negative, and ANA-negative patients
From: High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infection
RR-positive N (%) | RR-negative N (%) | ANA-negative N (%) | p-value | |
|---|---|---|---|---|
Age | 52.81 ± 9.7 | 54.71 ± 5.99 | 53.71 ± 10.77 | 0.9292A |
Female sex | 4 (36.36%) | 5 (71.42%) | 3 (45.07%) | 0.4217G |
Alcohol consumption | 6 (54.55%) | 3 (42.86%) | 33 (50%) | 0.8953G |
Smoking | 4 (36.36%) | 2 (28.57%) | 21 (31.34%) | 0.9350G |
Injectable drugs | 2 (18.18%) | 0 | 4 (6.06%) | 0.4200G |
Inhalant drugs | 2 (18.18%) | 0 | 5 (7.58%) | 0.4619G |
Previous hepatitis | 0 | 2 (28.57%) | 10 (14.71%) | 0.1722G |